Target
Cyclin-dependent kinase 9
Ligand
BDBM316201
Substrate
n/a
Meas. Tech.
Fluorescent Polarization Assay
IC50
<1000±n/a nM
Citation
 Lori, FChafouleas, JDe Forni, DSolinas, AVarga, ZGreff, ZÖrfi, LKéri, G 4,6-disubstituted aminopyrimidine derivatives have anti-HIV activity US Patent  US9617225 Publication Date 4/11/2017 
Target
Name:
Cyclin-dependent kinase 9
Synonyms:
C-2K | CDC2L4 | CDK9 | CDK9_HUMAN | Cell division cycle 2-like protein kinase 4 | Cell division protein kinase 9 | Cyclin-Dependent Kinase 9 (CDK9) | Cyclin-dependent kinase 9 (CDK9) | Serine/threonine-protein kinase PITALRE | TAK | Tat-associated kinase complex catalytic subunit
Type:
Enzyme Subunit
Mol. Mass.:
42789.13
Organism:
Homo sapiens (Human)
Description:
n/a
Residue:
372
Sequence:
MAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRRKGSQITQQSTNQSRNPATTNQTEFERVF
  
Inhibitor
Name:
BDBM316201
Synonyms:
2-methoxy-5-(6-(2-methoxyphenyl)pyrimidin-4-ylamino)benzaldehyde | US10294218, Example 29 | US9617225, Example 29
Type:
Small organic molecule
Emp. Form.:
C19H17N3O3
Mol. Mass.:
335.3566
SMILES:
COc1ccc(Nc2cc(ncn2)-c2ccccc2OC)cc1C=O
Structure:
Search PDB for entries with ligand similarity: